Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT-Reference-Cited by-同舟云学术

Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT

Published:2018-08 Issue: Volume:832 Page:39-49
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Mao Jie,Yang Hongbao,Cui Tingting,Pan Pan,Kabir Nadia,Chen Duo,Ma Jinyan,Chen Xingyi,Chen Yijun,Yang Yong

Funder

111 Project

National Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference40 articles.

1. Anticancer potential of silymarin: from bench to bed side;Agarwal;Anticancer Res.,2006

2. Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology;Berk;Asian Pac. J. Cancer Prev.: APJCP,2013

3. Hepatocellular carcinoma: clinical frontiers and perspectives;Bruix;Gut,2014

4. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial;Bruix;J. Hepatol.,2012

5. Rational approach to the clinical protocol design for drug combinations: a review;Chang;Acta Paediatr. Taiwan. = Taiwan er ke yi xue hui za zhi,2000

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma;Pharmaceutical Science Advances;2024-12

2. A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma;Anti-Cancer Agents in Medicinal Chemistry;2024-08-09

3. Molecular Evidence of the Bio-activities of Traditional Home Medicine Ingredients;Current Topics in Medicinal Chemistry;2024-07-02

4. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells;PLOS ONE;2024-03-25

5. A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment;Frontiers in Pharmacology;2024-02-29